Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (17/01/2025) announced the following list of price concessions for January 2025: Drug Pack size Price concession Acamprosate 333mg gastro-resistant tablets 168 £21.90 Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye
Read moreCommunity Pharmacy England has published new guidance to help community pharmacy owners complete the Data Security and Protection Toolkit 2025. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Friday 30th June 2025. Community Pharmacy England has collaborated with the NHS DSPTK team to keep the workload associated with
Read moreCommunity Pharmacy England has launched its fourth annual Pressures Survey, and all pharmacy owners and staff are asked to share their views. The survey provides crucial evidence as part of ongoing work to monitor and quantify the intolerable challenges facing the sector. Results will be used to raise awareness in the national media and Parliament,
Read moreThe NHS Business Services Authority (NHSBSA) has notified Community Pharmacy England that the Manage Your Service (MYS) Pharmacy portal will be unavailable due to essential maintenance between 7:00am and 6:00pm on the following days: Saturday 18 January 2025 Saturday 8 February 2025 Saturday 15 February 2025 Pharmacy owners will not be able to access the
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/01/2025) announced the following initial list of price concessions for January 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £3.80 Calcipotriol 0.005% / Betamethasone dipropionate 0.05%
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Xylocaine® (lidocaine) 10mg spray MSN/2025/003 Tier 2 medium impact Date of issue: 14th January 2025 Xylocaine® (lidocaine) 10mg spray is out of stock until mid-February 2025. Lidocaine 5% / Phenylephrine 0.5% spray remains available and can support an increase in demand.
Read moreMHRA Class 4 Medicines Defect Notification: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV) Drug alert number: EL(25)A/02 Date issued: 13 January 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Irbesartan 150 mg and 300 mg film-coated tablets (Jubilant Pharmaceuticals NV)
Read morePharmacy owners who submit their FP34C declaration through the Manage Your Service (MYS) portal by the 5th of the month (or by the 6th if one or more bank holiday occurs during the first five days of the month) will receive 100% of their advance payments four working days after the submission deadline. The table below
Read more“Pharmacy businesses need a clear pathway to a better future which they can both have confidence in and plan for,” says Community Pharmacy England Chief Executive Janet Morrison in a new blog. Community pharmacy owners are “exasperated and desperate” and the sector needs answers on a range of key issues. In her latest blog, Janet
Read moreBy Chief Executive Janet Morrison New year, new you… so the mantra goes. But for community pharmacy owners the start of 2025 will feel very much like the end of the last year. Already, just ten days in, we have seen national media coverage of pharmacy owners investing their personal savings to keep their business
Read more
